Synthetic Minds | Five Tech Giants Just Split Drug Discovery

OpenAI shipped GPT-Rosalind. Amazon launched Bio Discovery. Anthropic acquired Coefficient Bio. Isomorphic Labs got FDA Phase 1 clearance. Lilly built a 1,016-GPU AI factory. Five architectures, zero interoperability. The platform you pick determines who owns the intelligence beneath your science.

Read More